Business Insights, June 2011, Pages: 187
of the cancer diagnostics market including: breast, colorectal, prostate, lung, and renal cancer.
Highlights
Advances in genomics, proteomics, molecular imaging, and other new technologies are leading
Business Insights, Oct 2009, Pages: 141
of a cancer diagnosis
Pathology
Oncology diagnostics market
Chapter 2 Innovations in diagnosticimaging
Summary
Introduction
Body imaging
Overview
X-ray
Breast cancer
Computed tomography
Lung cancer
Decision Resources, Inc., Dec 2009, Pages: 34
Diagnosis and Targeted Treatment
Breast Cancer
Colorectal Cancer
Lung Cancer
What Are the Oncologists Saying?
Impact on Clinical Practice
Use of DiagnosticImaging
Genetic Biomarkers in Cancer Trials
Takeda Pacific, April 2012, Pages: 171
guidance papers to help drug makers and diagnostic firms develop future targeted therapies guided by companion diagnostics. The recent FDA approvals of Pfizer's Xalkori for lung cancer and Roche's Zelboraf
Jain PharmaBiotech, May 2012, Pages: 798
expression analysis
Monitoring in vivo gene expression by molecular imaging
Molecular imaging and personalized medicine
Glycomics-based diagnostics
Combination of diagnostics and therapeutics
Use
Jain PharmaBiotech, May 2012, Pages: 873
for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various
Business Insights, July 2010, Pages: 198
. In the clinical setting, imaging biomarkers can be used as a screening, diagnostic or prognostic tool as well as for monitoring treatment response.
Researchers have a vision that the introduction of imaging
Informa Healthcare, June 2008, Pages: 824
Pathology:
- is organized based on how the patient should be approached, and the patient’s own projections, signs, symptoms, and disease
- provides new imaging techniques and molecular diagnostic tests
Jain PharmaBiotech, May 2012, Pages: 225
abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images
Business Insights, Sep 2006, Pages: 126
Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare The global diagnostics market is undergoing radical change; novel technologies
Venture Planning Group, Nov 2011, Pages: 850
Future Japanese Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies This report presents a comprehensive analysis of the Japanese molecular diagnostics
Markets and Markets, Feb 2010, Pages: 185
in the field of healthcare image management software over the last decade. Healthcare equipment vendors are now seeking to provide an integrated diagnostic model facilitating patient-centric, evidence-based
TriMark Publications, July 2011, Pages: 267
of Cancer
4.4.1 Screening
4.4.2 Sigmoidoscopy
4.4.3 Imaging
4.4.4 Theranostics
5. Implications of Molecular Biology for New Diagnostic Cancer Tests
6. Companies Entering the Cancer Diagnostics
TriMark Publications, Feb 2012, Pages: 214
Inks Companion Diagnostic Deal with Syndax for Lung Cancer Drug
5.13.3 Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for the PRAME Antigen
5
Business Insights, March 2010, Pages: 185
the key demand for next generation omics based diagnostics.
Key findings from this report
- Mass spectrometry is used to identify potential circulating protein biomarkers for non-small cell lung cancer
Decision Resources, Inc., April 2007, Pages: 34
- Trends in Cancer Biomarker Development: Biomarker discovery and validation, as well as the role of the diagnostics.
- Emerging Biomarkers in Select Cancers: Bladder, breast, colorectal, lung, pancreatic
